TC
| |
TANG CAPITAL MANAGEMENT LLC13F | |
| TANG CAPITAL MANAGEMENT LLC | |
| Last update 2025-02-16 | 183 Stocks (41 new) |
| Value $1.51 Bil | Turnover 21 % |
TANG CAPITAL MANAGEMENT LLC Top Holdings of 2024-12-31
View Full List
| Ticker | | Company | Shares | Value ($1000) | Shares Change % | Weighting % | Trade Impact % | % of Shares outstanding | 3M Change % | YTD Change % | Market Cap $Mil | Industry |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
TARS | Tarsus Pharmaceuticals Inc | 2,254,797 | 124,848.1 | 0% | 8.260 | 0% | 5.900 | +2.50% | -9.70% | 2,080.4 | Biotechnology | |
AUPH | Aurinia Pharmaceuticals Inc | 8,429,500 | 75,696.9 | +16.60% | 5.010 | +0.71% | 5.890 | +2.25% | -8.91% | 1,117.8 | Biotechnology | |
GLPG | Galapagos NV | 2,161,200 | 59,433.0 | +208.74% | 3.930 | +2.66% | 3.280 | +13.33% | -2.33% | 1,770.1 | Biotechnology | |
EOLS | Evolus Inc | 4,997,399 | 55,171.3 | +3.09% | 3.650 | +0.11% | 7.890 | -18.13% | +5.53% | 740.8 | Drug Manufacturers | |
MIRM | Mirum Pharmaceuticals Inc | 1,237,107 | 51,154.4 | -3.88% | 3.380 | -0.14% | 2.580 | -14.16% | -1.33% | 2,017.7 | Biotechnology | |
VRDN | Viridian Therapeutics Inc | 2,492,925 | 47,789.4 | +11.15% | 3.160 | +0.32% | 3.150 | -26.83% | -29.58% | 1,100.0 | Biotechnology | |
IMCR | Immunocore Holdings PLC | 1,555,600 | 45,890.2 | +40.70% | 3.040 | +0.88% | 3.110 | -8.61% | +2.24% | 1,488.3 | Biotechnology | |
KALV | KalVista Pharmaceuticals Inc | 4,893,847 | 41,450.9 | +13.24% | 2.740 | +0.32% | 9.900 | +50.87% | +53.36% | 645.8 | Biotechnology | |
RLAY | Relay Therapeutics Inc | 8,068,058 | 33,240.4 | +126.12% | 2.200 | +1.23% | 4.820 | -34.02% | -22.33% | 545.6 | Biotechnology | |
REPL | Replimune Group Inc | 2,700,000 | 32,697.0 | +125.00% | 2.160 | +1.20% | 3.510 | -33.41% | -25.27% | 697.0 | Biotechnology |
TANG CAPITAL MANAGEMENT LLC's Historical Top Holdings Breakdowns
TANG CAPITAL MANAGEMENT LLC's Top Stock Picks
View Full List
| Ticker | | Company | Date | Action | Impact % | Price Range | Price | Price Change from Avrg% | Comment | Current Shares | Share Change |
|---|---|---|---|---|---|---|---|---|---|---|---|
GLPG | Galapagos NV | 2024-12-31 | Add | +2.66% | 25.22 ($27.87) 31.05 | $26.86 | -3.62% | Add 208.74% | 2,161,200 | 1,461,200 | |
ITOS | ITeos Therapeutics Inc | 2024-12-31 | Reduce | -1.60% | 7.22 ($8.57) 10.02 | $7.35 | -14.24% | Reduce -90.79% | 221,716 | -2,186,084 | |
RLAY | Relay Therapeutics Inc | 2024-12-31 | Add | +1.23% | 4.12 ($5.42) 6.8 | $3.20 | -40.96% | Add 126.12% | 8,068,058 | 4,500,000 | |
REPL | Replimune Group Inc | 2024-12-31 | Add | +1.20% | 10.54 ($12.16) 14.93 | $9.05 | -25.58% | Add 125% | 2,700,000 | 1,500,000 | |
LEGN | Legend Biotech Corp | 2024-12-31 | New Buy | +0.97% | 32.49 ($41.33) 50.26 | $34.28 | -17.06% | New holding | 450,000 | 450,000 | |
RVNC | Revance Therapeutics Inc | 2024-12-31 | Sold Out | -0.93% | 3.03 ($4.34) 5.92 | $3.65 | -15.90% | Sold Out | 0 | -2,500,000 | |
IMCR | Immunocore Holdings PLC | 2024-12-31 | Add | +0.88% | 28.14 ($31.62) 34.69 | $30.16 | -4.62% | Add 40.7% | 1,555,600 | 450,000 | |
MRNA | Moderna Inc | 2024-12-31 | New Buy | +0.83% | 36.85 ($47.54) 63.16 | $27.22 | -42.74% | New holding | 300,000 | 300,000 | |
IMNM | Immunome Inc | 2024-12-31 | Sold Out | -0.75% | 9.33 ($12.06) 14.53 | $8.40 | -30.35% | Sold Out | 0 | -720,000 | |
AUPH | Aurinia Pharmaceuticals Inc | 2024-12-31 | Add | +0.71% | 6.75 ($8.17) 10.44 | $8.18 | 0.12% | Add 16.6% | 8,429,500 | 1,200,000 |
TANG CAPITAL MANAGEMENT LLC Total Holding History ($B)
TANG CAPITAL MANAGEMENT LLC's Asset Allocation
TANG CAPITAL MANAGEMENT LLC Past Portfolios
| Portfolio Date | Number of Stocks | New Stocks | Total Value ($Mil) | Q/Q Turnover |
|---|---|---|---|---|
Top Ranked Articles
- 1
TANG CAPITAL MANAGEMENT LLC's Hypothetical Growth since 2024-12-31
TANG CAPITAL MANAGEMENT LLC's Yearly Returns
| Year | Portfolio % | % | Excess Gain % |
|---|
TANG CAPITAL MANAGEMENT LLC's Holdings Heat Map
Size field:
TANG CAPITAL MANAGEMENT LLC's Holdings Bubble Chart
TANG CAPITAL MANAGEMENT LLC News
- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers